KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Operating Expenses (2016 - 2025)

Johnson & Johnson's Operating Expenses history spans 17 years, with the latest figure at -$3.5 billion for Q4 2025.

  • For Q4 2025, Operating Expenses rose 3.64% year-over-year to -$3.5 billion; the TTM value through Dec 2025 reached $24.0 billion, down 3.73%, while the annual FY2025 figure was $24.0 billion, 3.73% down from the prior year.
  • Operating Expenses for Q4 2025 was -$3.5 billion at Johnson & Johnson, down from $9.7 billion in the prior quarter.
  • Across five years, Operating Expenses topped out at $10.5 billion in Q1 2021 and bottomed at -$16.7 billion in Q1 2022.
  • The 5-year median for Operating Expenses is $8.7 billion (2021), against an average of $5.4 billion.
  • The largest annual shift saw Operating Expenses tumbled 258.36% in 2022 before it surged 125.42% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $9.5 billion in 2021, then tumbled by 62.56% to $3.6 billion in 2022, then plummeted by 191.97% to -$3.3 billion in 2023, then dropped by 10.2% to -$3.6 billion in 2024, then rose by 3.64% to -$3.5 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Operating Expenses are -$3.5 billion (Q4 2025), $9.7 billion (Q3 2025), and $9.5 billion (Q2 2025).